Dr. Mohamed Abou-el-Enein, MD, PhD, MSPH

Affiliation

Executive Director, USC/CHLA Cell Therapy Program
Associate Professor of Clinical Medicine (Oncology), Pediatrics and Stem Cell Biology & Regenerative Medicine, Keck School of Medicine
University of Southern California

Committee membership

Stem Cell Oversight Committee

Biography

Dr. Abou-el-Enein is associate Professor of Clinical Medicine (Oncology), Pediatrics, and Stem Cell Biology & Regenerative Medicine at USC Keck School of Medicine and serves as the Executive Director of the Joint USC/CHLA Cell Therapy Program. He is also the Director of the cGMP facility at CHLA and the new unit under construction at USC. Dr. Abou-el-Enein is a nationally and internationally recognized expert in planning and executing clinical development programs, designing and operating academic GMP facilities, and in translating cell and gene therapy products from preclinical stage to clinical applications. He has over 11 years of experience in clinical research and regulatory affairs and has successfully brought several cell-based therapies to early phase clinical trials. Dr. Abou-el-Enein is a strong advocate for equitable access to safe and effective medical innovations. He is committed to addressing the risk associated with the global rise of clinics marketing unproven stem cell interventions.

Date modified:

2022-01-13